MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Safety, tolerability and CNS effects after single and multiple doses of β-agonists in healthy volunteers and patients with Parkinson’s disease

    P. Eijsvogel, S. Prins, L. Moss, L. Borghans, B. van Kraaij, E. van Brummelen, E. Klaassen, R. Martin, E. Bautista, A. Ford, GJ. Groeneveld, G. Vargas (Leiden, Netherlands)

    Objective: This study aimed to assess the effects of β-agonists on central nervous system (CNS) functioning in healthy volunteers and patients with Parkinson’s disease. Background:…
  • MDS Virtual Congress 2021

    Registry Analysis (In Progress) to Evaluate Clinical Outcomes and Disease Burden of Advanced PD in Patients With Motor Fluctuations and Dyskinesia Managed With Oral Dopaminergic Therapies Versus Device-Aided Therapies

    W. Hu, O. Ladhani, P. Kukreja, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To compare clinical outcomes of patients with Parkinson's disease (PD) with moderate and severe motor fluctuations or dyskinesia managed with oral dopaminergic medications vs…
  • MDS Virtual Congress 2021

    Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson’s Disease

    E. Londero, A P. Dos Santos, R. Braga, R. de Barros, L. Dos Reis, G. Freire (Salvador, Brazil)

    Objective: Our study aims to analyze the efficacy and safety of Levodopa-carbidopa intestinal gel (LCIG) in Parkinson's disease (PD). Background: Oral Levodopa is considered to…
  • MDS Virtual Congress 2021

    STATINS IN PARKINSON’S DISEASE: INFLUENCE ON MOTOR PROGRESSION

    G. Palermo, S. Giannoni, M. Giuntini, E. Belli, D. Frosini, G. Siciliano, R. Ceravolo (Pisa, Italy)

    Objective: To evaluate whether long-term statin use may affect motor progression in a large cohort of de novo patients with Parkinson's Disease. Background: Statins are…
  • MDS Virtual Congress 2021

    Pilot study of Phenotype of Antisense-Oligonucleotide-(ASO)-knockdown of Cerebral-Dopamine-Neurotrophic-Factor (CDNF) as Parkinson Disease model : implications for PD and related Dementia Therapeutics

    SS. Chiu, K. Terpstra, RK. Mishra (London, Canada)

    Objective: Our objective is twofold: 1)to examine whether CDNF-ASO paradigm can induce a unique phenotype mimicking PD/PDD/LBW in the rodent species; 2) to evaluate whether…
  • MDS Virtual Congress 2021

    Attitudes on therapy-associated risks in individuals with multiple system atrophy and Parkinson’s disease and their views on aspects of clinical trials

    AM. Bernhardt, T. Barthel, I. Friedrich, E. Kocakavuk, E. Nachman, M. Oeller, K. Peikert, M. Roderigo, A. Rossmann, LO. Wilhelm, M. Brandt, J. Classen, BH. Falkenburger, A. Frank, L. Hoegner, H. Jacobi, A. Janzen, S. Katzdobler, J. Nieweler, T. Prell, JJ. Rumpf, C. van Riesen, T. Warnecke, M. Weiler, F. Gandor, J. Levin, A. Giese, WH. Oertel (Munich, Germany)

    Objective: To assess risk attitudes of patients suffering from multiple system atrophy (MSA) and Parkinson’s disease (PD) on future disease-modifying therapies as well as related…
  • MDS Virtual Congress 2021

    Progression of nigro-striatal denervation in cerebellar Multiple System Atrophy: a prospective study

    T. Wirth, I. Namer, B. Monga, C. Bund, A. Iosif, O. Gebus, S. Montaut, T. Bogdan, L. Robelin, M. Renaud, S. Kremer, C. Tranchant, M. Anheim (Strasbourg, France)

    Objective: To study the progression of nigro-striatal denervation and evaluate the capacity for [123I]-FP-CIT-SPECT and parkinsonian signs to differentiate MSA-C from idiopathic late-onset cerebellar ataxia…
  • MDS Virtual Congress 2021

    Quantitative downgaze palsy predicts the survival duration in patients with progressive supranuclear palsy

    T. Xie, C. Yuen, W. Kang, M. Padmanaban, T. Han, J. Nichols (Chicago, USA)

    Objective: To study whether quantitative downgaze palsy could predict the survival duration in patients with progressive supranuclear palsy (PSP). Background: No clinical feature has been…
  • MDS Virtual Congress 2021

    Transcranial Magnetic Stimulation in Parkinsonism. Tremor and Biomechanics Evaluation

    D. Labunskiy, S. Kiryukhina, A. Hamed, N. Dzhalolitdinova, S. Abdulsahib (Saransk, Russian Federation)

    Objective: The aim of our study was to reveal the relationship between motor and muscle activity шт terms of plantar pressure distribution PPD) in Parkinson's…
  • MDS Virtual Congress 2021

    Post-Covid-19 Parkinson’s disease: a Brazilian case series.

    J. Tavares, D. Oliveira, S. Gaspar, C. Gomes, M. Neto, P. Neto (Fortaleza, Brazil)

    Objective: To describe two patients with post-COVID-19 Parkinson’s disease (PD) and discuss their possible causes. Background: PD is a neurodegenerative disorder characterized by motor and…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley